Search Results

The MEDRAD® MRXperion MR Injection System is a syringe‐based fluid delivery system indicated for delivery of contrast media and saline during MR applications. It is intended to be used for the specific purpose of injecting intravenous MR contrast media and saline into the human vascular system for diagnostic studies in magnetic resonance imaging (MRI) applications with MRI scanners. Only trained healthcare professionals are intended to operate this device. For a complete list of compatible contrast agents for use with the MEDRAD MRXperion MR Injection System, refer to the MRXperion MR Injection System Operation Manual. The ISI2 Module is indicated for the specific purpose of allowing an injector to interface with an imaging scanner.

The MRXperion Injection System is a software-controlled, electromechanical medical device used for the administration of intravenous MR contrast media and saline into the human vascular system for diagnostic studies in magnetic resonance imaging (MRI) procedures. Commonly referred to as an automated injection system, it is designed to allow a user to fill disposable syringes and then to perform an injection with a user-programmed volume and flow rate.

The MRXperion Injection System is comprised of a Scan Room Unit (SRU), Control Room Unit (CRU) and Single Use, Disposable Syringe Kit.

The SRU is located within the scan room whereas the control room unit is not. The SRU, via a wired connection, interfaces with the control room unit. The CRU, also known as the workstation, includes a graphical user interface for the injector. The operator can use the touchscreen display to manage protocols and initiate and execute injections. However, the SRU can be used to also initiate and execute injections.

The fluids are delivered from a single use only, sterile disposable set that includes one 65 mL syringe for contrast media and one 115 mL syringe for saline.

The injection system is intended to be used in an MR suite. The MR suite may be located in a mobile medical imaging trailer. The injection system is intended to be operated by personnel with training and experience in MR procedures and use of MR injection systems. Operators will consist of radiological technologists trained in the use of the equipment. This system is intended for use with the general patient population, including adults and pediatrics.

The MRXperion Injection System subject to this submission includes modified hardware and software as compared to the most recent clearance (K182276). The submission also includes an additional connectivity accessory, Imaging System Interface (ISI2) Module. The design changes do not involve any changes to the MRXperion MR Injection System Syringe Kit.

N/A

Ask a specific question about this device

The MEDRAD® MRXperion MR Injection System is a syringe-based fluid delivery system indicated for delivery of contrast media and saline during MR applications. It is intended to be used for the specific purpose of injecting intravenous MR contrast media and saline into the human vascular system for diagnostic resonance imaging (MR) applications with MRI scanners that have a magnetic field strength between 0.7 and 3.0 Tesla. Only trained healthcare professionals are intended to operate this device.

The MEDRAD MRXperion MR Injection System is a software-controlled medical device used for the administration of intravenous MR contrast media and saline into the human vascular system for diagnostic studies in magnetic resonance imaging (MRI) procedures. Commonly referred to as an automated injection system, it is designed to allow a user to fill disposable syringes and then to perform an injection with a userprogrammed volume and flow rate.

This document describes a 510(k) premarket notification for the MEDRAD MRXperion MR Injection System, which is an angiographic injector and syringe system. The submission is for a new control room unit (CRU) with integrated hardware components as an alternative to the existing CRU.

The document does not contain information related to an AI/ML powered medical device, therefore it does not provide the details required to answer questions 1-9 regarding acceptance criteria and study data for such a device. The device is a traditional medical device (an injection system) and the performance data described relates to its physical and functional attributes.

Here's a breakdown of what the document does provide and why it can't answer the specific questions about AI/ML acceptance criteria and studies:

What the document tells us about the device and its assessment:

• Device Name: MEDRAD MRXperion MR Injection System and MR Injection System Syringe Kit
• Regulation Number & Name: 21 CFR 870.1650, Angiographic Injector And Syringe
• Regulatory Class: Class II
• Product Code: DXT
• Predicate Device: MEDRAD MRXperion MR Injection System and MR Injection System Syringe Kit, K143538
• Changes from Predicate: A new control room unit (CRU) with integrated hardware components. The changes are described as "aesthetic improvement, modular design and serviceability." The document explicitly states: "The fundamental scientific technology, principle of operation, and indications for use are unchanged from the predicate device... The differences... do not introduce new issues of safety and effectiveness and do not change the indications for use or result in a different fundamental scientific technology."
• Performance Data (General): Verification and validation testing was conducted. This included:
  • Device performance testing (fluid delivery, flow rates, volumes, pressures).
  • Safety and Compatibility testing (configurations, circuitry, IEC 60601-1, EMC, electrical safety controls, failure detection, programming keys, sensors, safe operation).
  • Reliability testing (sequential and repeated performance, simultaneous operation with Informatics processes).
  • Simulated Use and Human Factors testing (per EN 62366-1: 2015 and FDA Guidance).
  • Cleaning and disinfection validation (per FDA Guidance "Reprocessing Medical Devices in Health Care Settings").
• Key Finding: "All testing passed and the demonstrated product performance met all prior established acceptance criteria." "All test results demonstrate that the design and materials... meet the established performance criteria and will perform as intended." "The results of the design verification and validation, including human factors engineering evaluation, demonstrate that the subject device is substantially equivalent to its predicate device."
• Clinical Testing: "No clinical testing was required or performed to support this Special 510(k) Premarket Notification." This is common for special 510(k)s where the design changes do not raise new questions of safety or effectiveness.

Why the requested information (1-9) cannot be extracted from this document:

The provided document is a 510(k) summary for a non-AI/ML medical device. The acceptance criteria and study design questions (specifically regarding sample size for test/training sets, data provenance, expert ground truth, MRMC studies, standalone performance, etc.) are standard requirements for AI/ML-powered medical devices. This document verifies the substantial equivalence of a physical medical injection system that has undergone minor design changes (specifically, the control room unit).

Therefore, I cannot provide answers to the specific questions regarding AI/ML device acceptance criteria and study details because the document is not about an AI/ML device.

Ask a specific question about this device